# Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial.

> PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-38697184-setmelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-05-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-38697184-setmelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38697184-setmelanotide-v1.json
- Content SHA-256: `3c1b196134967ca8ebaf926938730dd593d8dd5eb1b639e3a2c4ca68d17fa26b`

## Claims and source pins

### Headline

Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

### Summary

PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

### Paragraph 1

PubMed lists PMID 38697184 in The lancet. Diabetes & endocrinology as Journal Article, Clinical Trial, Phase II, Multicenter Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-04-30 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`](#source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b))

## Sources

<a id="source-pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b"></a>
- **Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial. · retained source version 1:2025-05-21:current:486d47792a4b58d582a695ac80e7fda867c70c8c71e0782d257403cda7cc77fc** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/38697184/) (`pubmed-observation-pmid-38697184-2025-05-21-486d47792a4b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-38697184-setmelanotide-v1.json SHA-256: 3c1b196134967ca8ebaf926938730dd593d8dd5eb1b639e3a2c4ca68d17fa26b.